Draig Therapeutics is a clinical-stage company with a mission to transform treatments in Neuropsychiatry. The company is leveraging its founders’ unique scientific expertise in modulating the core glutamate / GABA pathways that play a critical role in neuropsychiatric diseases to advance a pipeline of groundbreaking therapies designed to address large unmet patient needs, including in Major Depressive Disorder (MDD).
Draig is the Welsh word for ‘dragon’ and it reflects the company’s origins in Wales. The name and logo were inspired by this heritage, reflecting its scientific roots stemming from Cardiff University.
Company Details
- Employees
- 24
- Address
- Cardiff, Wales, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.draigtherapeutics.com
- HQ
- Cardiff, Wales
Draig Therapeutics Questions
Draig Therapeutics's website is http://www.draigtherapeutics.com
Draig Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/draigtherapeutics
Draig Therapeutics has
24 employees.
View email and phone details for 24
employees at Draig Therapeutics.
Draig Therapeutics's industry is
Biotechnology Research
Draig Therapeutics's top competitors are
Splicebio,
Portal Biotech,
Allay Therapeutics,
Antares Therapeutics,
Abselion,
Spyglass Pharma, Inc.,
Mosanna Therapeutics,
Touchlight,
Insmed Incorporated,
Actio Biosciences, Inc..
Draig Therapeutics's categories are Biotechnology Research
